Cutting-edge neuro-ophthalmology: Combining artificial intelligence, eye tracking
Technology with potential to improve treatment and evaluation of cortical visual impairment.
Technology with potential to improve treatment and evaluation of cortical visual impairment.
The data will be presented in oral session at the 2024 American Society of Gene & Cell Therapy meeting May 7-11 in Baltimore, Maryland.
Kamuvudine-8, also known as K8, is administered to the back of the eye via a sustained released intravitreal implant.
Researchers found the model demonstrated “near-perfect” detection capabilities.
David Hutton, Managing Editor of Ophthalmology Times sat down with Claris Bio CEO, Clarke Atwell, to discuss the company’s path toward developing treatment for neurotrophic…
Researchers examined disparities in service coverage of pediatric ophthalmologists and pediatric optometrists in relation to patient demographics to cast a light on at-risk populations and…
The data will be presented in oral session at the 2024 American Society of Gene & Cell Therapy meeting May 7-11 in Baltimore, Maryland.
The tool shows disease progression and vision loss simulations for multiple diseases such as AMD, XLRP, and achromatopsia
Rick Lewis, chief medical officer of ViaLase, describes the company’s nonincisional glaucoma treatment, showing promising safety and efficacy in studies and possibly paving the way…
Researchers found the model demonstrated “near-perfect” detection capabilities.
Donahue will serve as president until June 30, 2025, when he will host the AAPOS 2025 annual meeting in Salt Lake City, Utah. He previously…